康龙化成2025中期报告

康 龍 化 成（ 北 京 ）新 藥 技 術 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司）股份代號：3759 2025中期報告 300759.SZ/3759.HK200422,000 2453858596062646795 公司資料 20256 2020256 20 20256 2020256 20 97927 131 2022-2427-31 H 1617 618 3759. HK/300759.SZ 24840 www.pharmaron.cn 財務業績摘要 6,441.02024630836.514.9% 701.4202463037.0% 1,408.3202463028.1% A. 1. 21 B. 1. 20256,441.014.9%20253,342.120257.9%755.79.5%2025 406.3701.4PROTEOLOGIX, INC.37.0%1,408.328.1%254.1 10%20252,6004,510.270.0%480128.12.0%6,312.998.0% 201,167.948.0%18.1%5,273.19.5%81.9%4,072.611.0%63.2%1,234.230.5%19.2%973.015.5%15.1%161.28.8%2.5% 202563022,90820,68490.3%111,7002025802.28.9%12.4% 20252AI20257AI 2025ESGSBTi100%ISO 27001ISO 14001ISO 45001ISO 22301(United Nations GlobalCompact, UNGC)2025S&P Global(Industry Mover) 2. (1) 3,892.515.5%20252,035.220259.6%202544.9%0.910%202555.0%795 CN-Bio(AI)AIAIPROTACADC PROTACADC 202563010,7066,70020257Accelerator Mass SpectrometryAMSAMS (2)CMCCDMO CMCCDMO1,389.718.2%2025696.720250.5%202530.2%2.4CMCCDMO20%2025 2025630CMCCDMO4,811CMCCDMO84.0%2,500200(HTE) ADCGMP2025CMCCDMOCMCCDMO64123III21I-II188409 CDMO CMCCDMOCMCCDMOQA84381202411(FDA)(PAI)20254(EIR)20256FDAFDA20256CMCCDMOAPIGMP (3) 939.311.4%2025492.0202510.0%202512.3%0.3 20256304,41596 1,02789III389I/II549IV1507001,700 AI20252AIAI (4) 211.50.1%2025112.8202514.3%2025-54.7%CDMO2024 20256307522221317GLPnon-GLPCDMO161III5I/II10 CDMO2025GMPGMPGMPDNAINDCAR-TFDA 3. 4. 701.420246301,113.437.0%PROTEOLOGIX, INC. 5. 0.398420246300.628236.6%0.397820246300.627136.6% 6. (i)(ii)(iii) 7. 1,408.32024630308.528.1% 1,737.320246301,726.716,216.8%12)PROTEOLOGIX, INC. 101.020246304,552.097.8% 8. 20256301,208.81,408.3 20256307,593.1202412317,608.24,977.7202412314,224.020256301.5202412311.8 9. 20256305,542.81,333.54,209.3 202563041.0%2024123140.6% 10. 2025630901.7202412311,102.7124.120241231138.3 202563092.92024123166.8 11. 2025630 12. (1)2024 2025620202420242025714H202573A0.220255292025620 (2) 1.8551.39%20252AIAI (3) 202573,500AIAI (4) 20257(AI) (5) 10,00020254 (6) Pharmaron UK Limited3,000BLC HealthcareUSD Fund I L.P.Pharmaron UK Limited (7) 20254252025620202542520254272025429 202562020255292025620 (8) (i)(ii)20256202025326202562020255292025620 C. 1 ADC (1) CADDGMPGMP (2) AMSADMEDMPK/ADMEDMPK (3)POC IND (4) III III IV2025AI AIGDPRHIPAA(CSCO)30(RWD)FDAEMA(RWS) IND CRO (5)-IND ( C D M O )-IND2024200L2,000L -INDICHGLP/GCP/GMPGMP NMPAFDAOECD GLPIND (6) 2024FDAADCADCOligonucleotidessiRNA ASOADC 2 2111 INDIND CMCCDMOPharmaGendCDMO(FDA)(HSA)(Swissmedic)QP 3 (AI)(AI)AIAIAIAI 4 Boliang Lou3015 4312823,700202563020,684 202548098% D. 2025 1. 20252024 2. (1) (2) (3) (4) FDANMPA (5) (6) 2015 (7) (8) CMCCDMO CRO+CDMO (9) (10) (11)(AI) (AI)(AI) AIAI E. 1. (1) ISO 1400120301100%ISO 140012025 (2) (SBTi)SBTi202395% 100%2023203510% 203510% 2023203530%202420234% (3) 202478%2025100% (4) 2024 2024SEE 71%(AAALAC)2030100%AAALAC3AAALAC 2. (1)(DEI) DEI100% (2) 20252025203010% (3) 2024309 (4) ISO 450012030ISO 45001100% (LTIR)2030(LTIR)0.6 02030100% 3. (1) 20257(UNGC)100%ISO 2700120253ISO 270012030ISO 270012050ISO 27001 100%2024202495%100% 100% 100% 20252030100% (2) ESG 2030100% 72030100% ESG203090%ESG 203085% 2035100% 2025ISO 223012050100%ISO 22301 SBTi2023203361%2024198.4020237%2024 203080% (3) 2024 (4) 89 補充資料 2025630 2025429 C1 C.2.1 C1C.2.1(i)(ii)(iii) C3 B.13 202563022,9082024123121,370 542,000H7.320256307,263,300H542,000H2024126,721,300H7,263,300H2025H2025620 2025429202420256307,263,300H2025H 2025630 13.2013.2113.22 12.(7)13.51B(1)13.51B(2) 3.21C1 2025630XVXV78352 1.2025630Pharmaron Holdings Limited180,496,500A76.76% 202563060,540,050A40,135,026A 202563015,750,000A21,956,986A 20256304,333,988A 20181019 2025630323,212,550A 2. 2025630XV(i)XV78(ii)352(iii) 2025630336XV235% 1.LSP 2.2025630Pharmaron Holdings Limited180,496,500A76.76% 202563060,540,050A40,135,026A 202563015,750,000A21,956,986A 20256304,333,988A 20181019 2025630323,212,550A 3.242,800,00028,498,500A50.16%603072.74%80% 2021A 20217122021A2021A2021A (i)2021 A 2021A (ii)2021 A 2021AA2042021A2021A 5%2021A (iii) 2021AA 2021A2021A121% 2021AA1,161,30020211,741,950202220256300.1%1% (iv) 2021AA70.472021AA2021A12050%70.47 1.2021A150%A92.57 2.2021A2050%A89.86 3.2021A6050%A77.47 4.2021A12050%A70.47 A 20212021A20227282021AA70.1746.48 20222021A202310272021AA46.4830.79 20232021A20248272021AA30.7930.59 20242021A20258212021AA30.5930.39 (v)A 2021A2021A (vi)A 20251A2024,459AA202525 157347,001A20251 23 (vii) A25%25%25%25% A (1)202430.5930.39(1)2021A(iv)A (2)A24.65 (viii)2021 A 2021A2021AA6020256302021A12 (ix) 120258212021A42,189A2021A 2022A 20225312022A2022A2022A (i)2022 A 2022A (ii)2022 A 2022A3792022A2022A 5%2022A (iii) 2022AA 2022A2022A121% 2022A2,203,200A20213,304,800A202220256300.19%1% (iv) 2022AA58.382022AA 1.2022A1A50%A58.38